[2007-10-02 13:36]

Skanditeks subsidiary CMA Microdialysis AB launches system for continuous bedside glucose monitoring

CMA Microdialysis AB (CMA) today announced the launch of the new CE-approved IView Catheter,
which enables highly accurate tight glycemic control (TGC) in the Intensive Care Unit (ICU).

Skanditek holds 78 percent of it´s subsidiary CMA Microdialysis.

As to the rest, we refer to enclosed press release from CMA Microdialysis AB.


SKANDITEK INDUSTRIFÖRVALTNING AB (publ)


For further information, please contact:

Patrik Tigerschiöld, President and CEO,
telephone +46-8-614 00 20,

Philip Siberg, CEO CMA Microdialysis,
mobil +46 70 790 67 43, e-post philip.siberg@microdialysis.se

Skanditek is an industrial holding company owning stock in Swedish companies. The business concept is to be an active and long-term stockholder and to further the portfolio companies´ development by providing industrial and financial competence at board and management level. The portfolio comprises 9 companies within technology, biotechnology and services. The major holdings are in Bure Equity (17%), MYDATA automation (95%), PartnerTech (36%),and Vitrolife (25%). Skanditek is listed on the OMX Nordic List.

Denna information skickades av Cision http://newsroom.cision.com

Följande filer finns att ladda ned:

Pressrelease with appendix